Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Oriental Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of both Traditional Chinese Medicine (TCM) and modern chemical pharmaceuticals. Established in 1992 and headquartered in Shenzhen, the company operates GMP-certified facilities that produce a variety of dosage forms, including tablets, capsules, and granules. Its product portfolio is primarily focused on therapeutic areas such as cardiovascular health, respiratory conditions, and infectious diseases. Key products include Compound Danshen Tablets and various antibiotic formulations. The company serves the domestic Chinese market and maintains a reputation for quality in regional pharmaceutical manufacturing, integrating traditional herbal knowledge with modern pharmacological standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Oriental Pharmaceutical.